References
- Armoni M, Harel C, Bar-Yoseph F, Milo S, Karnieli E. Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements. J Biol Chem 280, 34786–34795. 2005.
- Asp ML, Collene AL, Norris LE, Cole RM, Stout MB, Tang SY, Hsu JC, Belury MA. Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes, a randomized, double-masked, crossover study. Clin Nutr 30, 443–449, 2011.
- Barre DE, Griscti O, Mizier-Barre KA, Hafez K. Flaxseed oil and lipoprotein (a) significantly increase bleeding time in type 2 diabetes patients in Cape Breton, Nova Scotia, Canada. J Oleo Sci 54, 347–354, 2005a.
- Barre DE, Griscti O, Mizier-Barre KA, Hafez K. The mechanism by which flaxseed oil consumption increases bleeding time in patients with type 2 diabetes in Cape Breton, Nova Scotia, Canada is independent of lipoprotein (a) concentration. J Oleo Sci 54, 617–625, 2005b.
- Barre DE, Mizier-Barre KA, Griscti O, Hafez K. High dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabetics. J Oleo Sci 57, 269–273, 2008.
- Blaak EE. Fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 62, 753–760, 2003.
- Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18, 139–143, 2011.
- Butler TJ, Barriocanal LA, Walker M. Elevated plasma non-esterified fatty acid levels and insulin secretion in non-diabetic relatives of type 2 diabetic patients. Clin Endocrinol (Oxf) 55, 349–355, 2001.
- Crochemore IC, Souza AF, de Souza AC, Rosado EL. ω-3 polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity. Nutr Clin Pract 27, 553–560, 2012.
- De Caterina R, Madonna R, Bertolotto A, Schmidt EB. n-3 fatty acids in the treatment of diabetic patients, biological rationale and clinical data. Diabetes Care 30, 1012–1026, 2007.
- Delarue J, Magnan C. Free fatty acids and insulin resistance, Curr Opin Clin Nutr Metab Care 10, 142–148, 2007.
- Eriksson J, Saloranta C, Widen E, Ekstrand A, Franssila-Kallunki A, Schalin C, Groop L. Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34, 192–197, 1991.
- Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med Sci Sports Exerc 36, 814–820, 2004.
- Ezaki O, Takahashi M, Shigematsu T, Shimamura K, Kimura J, Ezaki H, Gotoh T. Long-term effects of dietary alpha-linolenic acid from perilla oil on serum fatty acids composition and on the risk factors of coronary heart disease in Japanese elderly subjects. J Nutr Sci Vitaminol (Tokyo) 45, 759–772, 1996.
- Fontes G, Semache M, Hagman DK, Tremblay C, Shah R, Rhodes CJ, Rutter J, Poitout V. Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. Diabetes 58, 2048–2058, 2009.
- Foster M, Petocz P, Caterson ID, Samman S. Effects of zinc and α-linolenic acid supplementation on glycemia and lipidemia in women with type 2 diabetes mellitus, a randomized, double-blind, placebo-controlled trial. Journal of Diabetes Research and Clinical Metabolism 2, 3, 2013.
- Glauber H, Wallace P, Griver K, Brechtel G. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108, 663–668, 1998.
- Goh Y, Jumpsen J, Ryan E, Clandinin M. Effect of omega 3 fatty acid on plasma lipids, cholesterol and fatty acid content in NIDDM patients. Diabetologia 40, 45–52, 1997.
- Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW. Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS One 7, e48852, 2012.
- Hamazaki K, Itomura M, Hamazaki T, Sawazaki S. Effects of cooking plant oils on recurrent aphthous stomatitis, a randomized, placebo-controlled, double-blind trial. Nutrition 22, 534–538, 2006.
- Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance, time for a reevaluation. Diabetes 10, 2441–2449, 2011.
- Kelpe CL, Moore PC, Parazzoli SD, Wicksteed B, Rhodes CJ, Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 278, 30015–30021, 2003.
- Liu L, Li Y, Guan C, Li K, Wang C, Feng R, Sun C. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B Analyt Technol Biomed Life Sci 878, 2817–2825, 2010.
- Hawkins M, Tonelli J, Kishore P, Stein D, Ragucci E, Gitig A, Reddy K. Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes. Diabetes 52, 2748–2758, 2003.
- Maris M, Waelkens E, Cnop M, D’Hertog W, Cunha DA, Korf H, Koike T, Overbergh L, Mathieu C. Oleate-induced beta cell dysfunction and apoptosis, a proteomic approach to glucolipotoxicity by an unsaturated fatty acid. J Proteome Res 10, 3372–3385, 2011.
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419, 1985.
- McManus R, Clandinin M, Jumpson J, Finegood DT, Clandinin MT, Ryan EA. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type 2 diabetes. Diabetes Care 19, 463–467, 1996.
- Mehta A, Oeser AM, Carlson MG. Rapid quantitation of free fatty acids in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 719, 9–23, 1998.
- Montori V, Wollan P, Farmer A, Dinneen S. Fish oil supplementation in type 2 diabetes. Diabetes Care 23, 1407–1415, 2000.
- Moore PC, Ugas MA, Hagman DK, Parazzoli SD, Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 53, 2610–2616, 2004.
- Morita S, Shimajiri Y, Sakagashira S, Furuta M, Sanke T. Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes, a long-term follow-up study. Diabet Med 29, 980–985, 2012.
- Muramatsu T, Yatsuya H, Toyoshima H, Sasaki S, Li Y, Otsuka R, Wada K, Hotta Y, Mitsuhashi H, Matsushita K, Murohara T, Tamakoshi K. Higher dietary intake of alpha-linolenic acid is associated with lower insulin resistance in middle-aged Japanese. Prev Med 50, 272–276. 2010.
- Nakamura N, Hamazaki T, Kobayashi M, Ohta M, Okuda K. Effects of eicosapentaenoic acids on remnant like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus. In vivo 12, 311–314, 1998.
- Nettleton J, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes. J Am Dietetic Assoc 105, 428–440, 2005.
- Newens KJ, Thompson AK, Jackson KG, Wright J, Williams CM. Acute effects of elevated NEFA on vascular function, a comparison of SFA and MUFA. Br J Nutr 105, 1343–1351, 2011.
- Wang DQ, Liu XL, Rong QF, Han L, Zhao NQ. Alpha-linolenic acid improves insulin sensitivity in obese patients. Zhonghua Yi Xue Za Zhi 93, 132–134, 2013.
- Oprescu AI, Bikopoulos G, Naassan A, Allister EM, Tang C, Park E, Uchino H, Lewis GF, Fantus IG, Rozakis-Adcock M, Wheeler MB, Giacca A. Free fatty acid-induced reduction in glucose-stimulated insulin secretion, evidence for a role of oxidative stress in vitro and in vivo. Diabetes 56, 2927–2937, 2007.
- Parker SM, Moore PC, Johnson LM, Poitout V. Palmitate potentiation of glucose-induced insulin release, a study using 2-bromopalmitate. Metabolism 52, 1367–1371, 2003.
- Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults, implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32, 619–634, 2007.
- Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS. Regulation of the insulin gene by glucose and fatty acids. J Nutr 136, 873–876, 2006.
- Poitout V, Robertson RP. Glucolipotoxicity, fuel excess and beta-cell dysfunction. Endocr Rev 29, 351–366, 2008.
- Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontes G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801, 289–229, 2010.
- Reaven GM, Chen Y. Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus. Am J Med 85, 106–112, 1988.
- Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19, 1207–1213, 1996.
- Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53, 119–124, 2004.
- Roscoe JT. Fundamental Research Statistics for the Behavioral Sciences. Second Edition. Holt, Reinhart and Winston, Montreal 217, 1975.
- Salgin B, Ong KK, Thankamony A, Emmett P, Wareham NJ, Dunger DB. Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes. J Clin Endocrinol Metab 97, 302–309, 2012.
- Stefan N, Kantartzis K, Celebi N, Staiger H, Machann J, Schick F, Cegan A, Elcnerova M, Schleicher E, Fritsche A, Haring HU. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 33, 405–407, 2010.
- Taylor CG, Noto AD, Stringer DM, Froese S, Malcolmson L. Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 29, 72–80, 2010.
- Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495, 2004.
- Woodman R, Mori T, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 76, 1007–1015, 2002.
- Yang J, Xu G, Hong Q, Liebich HM, Lutz K, Schmulling RM, Wahl HG. Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J Chromatogr B Analyt Technol Biomed Life Sci 813, 53–58, 2004.
- Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets 7, 65–74, 2007.
- Yi L, He J, Liang Y, Yuan D, Gao H, Zhou H. Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients. Chem Phys Lipids 150, 204–216, 2007.